Mersen (MRN) Q4 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 TU earnings summary
3 Feb, 2026Executive summary
Achieved record annual consolidated sales of €1,244 million for 2024, with 2.6% organic growth, both segments contributing, and Q4 sales outperforming expectations despite headwinds in solar and semiconductors.
Q4 sales were virtually stable on an organic basis, down 0.6% year-over-year, but reported growth was 3.2% due to acquisitions.
Adjusted operating margin guidance for 2024 raised to 10.5%, at the upper end of forecasts, due to better-than-expected Q4 performance.
Financial highlights
More than 2% of annual organic growth was attributable to price increases, with acquisitions and disposals supporting growth.
Foreign exchange had a negative impact of nearly €9 million, while scope changes contributed €11 million positively.
Non-recurring items remained close to €25 million, mainly related to adaptation plan expenses.
Net debt projected below €400 million at year-end, better than previous guidance, due to efficient stock reduction.
CapEx guidance for 2024 maintained at around €220 million.
Outlook and guidance
Management remains confident in medium- and long-term prospects, citing a well-balanced international footprint.
Operating margin before non-recurring items for 2024 expected at close to 10.5%, at the upper end of the 10–10.5% forecast range.
2025 is expected to improve as overstocking in solar and semiconductors normalizes, but guidance will be updated in March.
Price effects are expected to moderate in 2025, with less inflationary support and more pressure in Asia.
Solar market expected to slow in early 2025, with SiC semiconductor market affected by a three-year demand delay.
Latest events from Mersen
- Resilient 2025 with €1,186m sales, 16% EBITDA margin, and positive cash flow; growth ahead.MRN
H2 202518 Mar 2026 - Medium-term financial targets postponed to 2029 amid sector delays and cost-saving initiatives.MRN
CMD 20243 Feb 2026 - Record sales and robust cash flow in 2024; 2025 outlook stable amid sector headwinds.MRN
H2 20243 Feb 2026 - 2025 sales fell 3.2% organically, but margins and capex guidance were maintained.MRN
Q4 2025 TU3 Feb 2026 - Record H1 sales and margin growth, with US expansion and 2024 guidance confirmed.MRN
H1 20242 Feb 2026 - Q3 growth slowed to 1.2% amid solar and semiconductor weakness; 2024 guidance revised down.MRN
Q3 2024 TU19 Jan 2026 - Q1 2025 sales fell 2.5% to €305m as solar and SiC slumped, but wind and rail grew strongly.MRN
Q1 2025 TU23 Dec 2025 - H1 2025: Sales down, but margins, cash flow, and guidance held firm; leverage at 2.2x.MRN
H1 202516 Nov 2025 - Record sales, robust cash flow, and all resolutions passed; focus on renewables and SiC.MRN
AGM 202515 Nov 2025